Cargando…

Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study

There is an acute need for advances in pharmacologic therapies and a better understanding of novel drug targets for severe asthma. Imatinib, a tyrosine kinase inhibitor, has been shown to improve forced expiratory volume in 1 s (FEV(1)) in a clinical trial of patients with severe asthma. In a pilot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baek, Seung Han, Foer, Dinah, Cahill, Katherine N., Israel, Elliot, Maiorino, Enrico, Röhl, Annika, Boyce, Joshua A., Weiss, Scott T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064376/ https://www.ncbi.nlm.nih.gov/pubmed/33805900 http://dx.doi.org/10.3390/jpm11040240

Ejemplares similares

Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
por: Ge, Derek, et al.
Publicado: (2022)

Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352
por: Foer, Dinah, et al.
Publicado: (2021)

Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19
por: Wang, Liqin, et al.
Publicado: (2020)

Improving Mobile Health for Asthma in a Pandemic: Patient Use of an Integrated COVID-19 Screener
por: Foer, Dinah, et al.
Publicado: (2022)

Post–Acute COVID-19 Respiratory Symptoms in Patients With Asthma: An Electronic Health Records–Based Study
por: Wang, Liqin, et al.
Publicado: (2023)

Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
por: Foer, Dinah, et al.
Publicado: (2021)

Network Diffusion Approach to Predict LncRNA Disease Associations Using Multi-Type Biological Networks: LION
por: Sumathipala, Marissa, et al.
Publicado: (2019)

Personalized Approach to Severe Asthma
por: Heffler, Enrico, et al.
Publicado: (2018)

Laughter: A Scientific Investigation
por: Foer, Joshua
Publicado: (2001)

Los desafíos de la memoria
por: Foer, Joshua

Dose-dependent severe cutaneous reactions to imatinib
por: Ugurel, S, et al.
Publicado: (2003)

The role of 15 lipoxygenase 1 in asthma comes into focus
por: Boyce, Joshua A.
Publicado: (2022)

A mixed-integer linear programming approach to the reduction of genome-scale metabolic networks
por: Röhl, Annika, et al.
Publicado: (2017)

LTC(4) synthase polymorphism modifies efficacy of botanical seed oil combination in asthma
por: Kazani, Shamsah, et al.
Publicado: (2014)

Imatinib Plasma Monitoring-Guided Dose Modification for Managing Imatinib-Related Toxicities in Gastrointestinal Stromal Tumor Patients
por: Yoon, Shinkyo, et al.
Publicado: (2013)

Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
por: Howarth, Peter, et al.
Publicado: (2020)

Protein interaction networks provide insight into fetal origins of chronic obstructive pulmonary disease
por: Röhl, Annika, et al.
Publicado: (2022)

Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications
por: Park, Sook Ryun, et al.
Publicado: (2016)

Discovering the genes mediating the interactions between chronic respiratory diseases in the human interactome
por: Maiorino, Enrico, et al.
Publicado: (2020)

Author Correction: Discovering the genes mediating the interactions between chronic respiratory diseases in the human interactome
por: Maiorino, Enrico, et al.
Publicado: (2021)

Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma
por: Wardlaw, Andrew, et al.
Publicado: (2020)

The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010)

PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes
por: Wang, Liqin, et al.
Publicado: (2022)

Single Cell Transcriptomic Analysis Reveals Organ Specific Pericyte Markers and Identities
por: Baek, Seung-Han, et al.
Publicado: (2022)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
por: Laidlaw, Tanya M, et al.
Publicado: (2023)

Asthma Is More Severe in Older Adults
por: Zein, Joe G., et al.
Publicado: (2015)

Primary imatinib failure rescued by dasatinib and maintained by reintroduction of imatinib
por: Kumar, Rajiv, et al.
Publicado: (2017)

No audible wheezing: nuggets and conundrums from mouse asthma models
por: Boyce, Joshua A., et al.
Publicado: (2005)

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
por: Menzies-Gow, Andrew, et al.
Publicado: (2023)

Impact of Asthma on the Severity of Serious Pneumococcal Disease
por: Dhillon, Ravneet K, et al.
Publicado: (2011)

Idiopathic hypereosinophilic syndrome presenting with severe vasculitis successfully treated with imatinib
por: Fraticelli, Paolo, et al.
Publicado: (2016)

Corticosteroid suppression of lipoxin A(4 )and leukotriene B(4)from alveolar macrophages in severe asthma
por: Bhavsar, Pankaj K, et al.
Publicado: (2010)

Exploiting the promiscuity of imatinib
por: Lee, Shun J, et al.
Publicado: (2009)

Imatinib-induced pancreatitis
por: Varma, Mahesh R., et al.
Publicado: (2010)

Reintroduction of Imatinib in GIST
por: Reid, T.
Publicado: (2013)

Imatinib Use in Pregnancy
por: Webb, Michael J, et al.
Publicado: (2012)

Imatinib-Induced Psoriasis
por: Atalay, Figen, et al.
Publicado: (2013)

The Side Effects of Imatinib
por: Uzer, Elmas, et al.
Publicado: (2013)

Imatinib-induced Gynecomastia
por: Gupta, Pragya, et al.
Publicado: (2019)

Is it severe asthma or asthma with severe comorbidities?
por: Brussino, Luisa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_be1hi7ovcvi50tpvujvr072s1h